Gynecologic Oncology Volume 160 Issue 1 to 3

The journal Gynecologic Oncology is an international publication dedicated to sharing clinical and investigative articles that explore tumors associated with the female reproductive tract. The journal publishes research related to the cause, diagnosis, and treatment of female cancers, in addition to studies from all disciplines linked to this area of study.

Among the areas of research included in Gynecologic Oncology are:

• Cell and Molecular Biology: The journal publishes findings from research on the cellular and molecular aspects of gynecologic oncology, which can include understanding the behavior of cancer cells, their interaction with the body, and the role of genes in the development and progression of these cancers.
• Chemotherapy: Studies related to the use of drugs to treat female reproductive tract cancers are featured, which can include investigations into new drugs, drug combinations, or the impact of chemotherapy on specific cancers or groups of patients.
• Cytology: This includes research on the microscopic examination of cells to detect cancer in the female reproductive system.
• Endocrinology: The journal features research on the role of hormones and the endocrine system in the development, progression, and treatment of female reproductive tract cancers.
• Epidemiology: Studies that explore the incidence, distribution, and potential control of female cancers on a population level are included.
• Genetics: Gynecologic Oncology publishes studies that explore the role of genes and genetic mutations in the development and progression of female reproductive tract cancers.
• Gynecologic Surgery: Research related to surgical interventions for female reproductive tract cancers, including new surgical techniques, patient outcomes following surgery, and the role of surgery in a comprehensive treatment plan is featured.
• Immunology: The journal features research on the role of the immune system in the prevention, development, and treatment of female reproductive tract cancers.
• Pathology: Research that involves the study of the causes and effects of female reproductive tract cancers at the tissue and organ level is published.
• Radiotherapy: Studies on the use of radiation to treat female reproductive tract cancers are featured. This can include research on new radiotherapy techniques, patient outcomes, and the role of radiotherapy in a comprehensive treatment plan.

Other kinds of articles, such as narrative reviews, survey articles, case reports, case series, letters to the editor about previously published manuscripts, and other short communications can be submitted to Gynecologic Oncology‘s open access companion title, Gynecologic Oncology Reports.

The journal emphasizes submissions that aim to understand, address, or eliminate health disparities. This could be disparities based on race, ethnicity, sexual orientation, sex, gender identity or expression, religion, national origin, age, disability, marital status, or social determinants of health. The journal actively encourages research that contributes to reducing health inequities and improving healthcare accessibility.

Volume 160, Issue 1: Pages 1-360 (January 2021)

Volume 160, Issue 2: Pages 361-642 (February 2021)

Volume 160, Issue 3: Pages 643-850 (March 2021)